Share of tuberculosis patients with HIV in Myanmar
Myanmar: Share of tuberculosis patients with HIV was 6.2% in 2024. ▼ Falling
Share of tuberculosis patients with HIV in Myanmar, 2000–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
In 2024, share of tuberculosis patients with hiv in Myanmar stood at 6.2%.
That represents a change of down 6.1% on the previous year and down 43.6% over ten years.
Over the whole period, share of tuberculosis patients with hiv in Myanmar peaked at 14.0% in 2000 and was at its lowest, 6.0%, in 2022.
Myanmar ranks 70th of 179 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 25 years of available data.
Share of tuberculosis patients with HIV in Myanmar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 14.0% | — |
| 2001 | 12.0% | -14.3% |
| 2002 | 11.0% | -8.3% |
| 2003 | 11.0% | +0.0% |
| 2004 | 11.0% | +0.0% |
| 2005 | 11.0% | +0.0% |
| 2006 | 11.0% | +0.0% |
| 2007 | 11.0% | +0.0% |
| 2008 | 11.0% | +0.0% |
| 2009 | 11.0% | +0.0% |
| 2010 | 10.0% | -9.1% |
| 2011 | 9.9% | -1.0% |
| 2012 | 9.7% | -2.0% |
| 2013 | 9.2% | -5.2% |
| 2014 | 11.0% | +19.6% |
| 2015 | 8.9% | -19.1% |
| 2016 | 9.5% | +6.7% |
| 2017 | 8.7% | -8.4% |
| 2018 | 8.5% | -2.3% |
| 2019 | 7.8% | -8.2% |
| 2020 | 8.5% | +9.0% |
| 2021 | 7.1% | -16.5% |
| 2022 | 6.0% | -15.5% |
| 2023 | 6.6% | +10.0% |
| 2024 | 6.2% | -6.1% |
Myanmar compared with similar countries
- Myanmar's 6.2% is above the median for lower middle income countries, which is 4.9%, 1.3× the median. (46 countries reporting)
- Myanmar's 6.2% is above the median for East Asia & Pacific, which is 1.2%, 5.2× the median. (27 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.4% | 11.0% | 14.0% | 10 |
| 2010s | 9.3% | 7.8% | 11.0% | 10 |
| 2020s | 6.9% | 6.0% | 8.5% | 5 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is share of tuberculosis patients with hiv in Myanmar?
- Share of tuberculosis patients with hiv in Myanmar was 6.2% in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest share of tuberculosis patients with hiv recorded in Myanmar?
- The highest recorded value was 14.0% in 2000.
- What is the lowest share of tuberculosis patients with hiv recorded in Myanmar?
- The lowest recorded value was 6.0% in 2022.
- How does Myanmar rank for share of tuberculosis patients with hiv?
- Myanmar ranks 70th out of 179 countries with data for 2024.
- Is share of tuberculosis patients with hiv rising or falling in Myanmar?
- Over the last ten years it is down 43.6%. The long-run trend across the full record is falling.
- Where does this Myanmar data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Share of tuberculosis patients with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The estimated share of people with tuberculosis who also have HIV.